Health: Oncology R & D: the medical perennial, Otsuka set to...

To view this email as a webpage, click here     Friday September 06 2013     Health   Oncology R & D: the medical perennial   A fortune has been spent on cancer research in the past few decades, and it is hardly about to slow down, but it may become harder to squeeze out diminishing returns       Otsuka set to buy US drugmaker Astex     Suntory nears Ribena and Lucozade deal     Drinks, drugs and cars dodge downturn     India clears $1.6bn Mylan-Agila deal               Manage email    Forward this email   Feedback    Manage portfolio Subscribe to the FT Follow the FT   Unsubscribe | My Account | RSS | Privacy Policy | About Us | Help   © THE FINANCIAL TIMES LTD 2013 You have received this email because you have signed up from the NBE preference page. This email was sent by a company owned by Pearson plc, registered office at 80 Strand, London WC2R 0RL. Registered in England and Wales with company number 53723.